G

GeneCentric Therapeutics, Inc.

16 employees

GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Lung Cancer Diagnostics and Hypoxia Signature
Health Care

Date founded

2011

Funding rounds raised

Total raised

$7.5M

from 4 investors over 4 rounds

G

GeneCentric Therapeutics, Inc. raised $2.5M on September 20, 2022

Investors: IAG Capital Partners

G

GeneCentric Therapeutics, Inc. raised $7.5M on November 8, 2021

Investors: Labcorp and IAG Capital Partners

G

GeneCentric Therapeutics, Inc. raised $5M on July 23, 2014

Investors: Dow Jones

FAQ